Marc Lang

New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis

Guido Bold, Karl‐Heinz Altmann, J Frei et al. · Journal of Medicinal Chemistry · 2000 · 213 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Use of a Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors:  4-(Phenylamino)pyrazolo[3,4-<i>d</i>]pyrimidines

Peter Traxler, Guido Bold, Joerg Frei et al. · Journal of Medicinal Chemistry · 1997 · 205 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors:  Candidates for Clinical Development

Guido Bold, Alexander Fässler, Hans‐Georg Capraro et al. · Journal of Medicinal Chemistry · 1998 · 199 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805

Fabienne Baffert, Catherine H. Régnier, Alain De Pover et al. · Molecular Cancer Therapeutics · 2010 · 120 citations

Medicine, Molecular Biology, Pharmacology +13

Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral Bioavailability

Alexander Fässler, Guido Bold, Hans‐Georg Capraro et al. · Journal of Medicinal Chemistry · 1996 · 78 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15